Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. IHC-p: 1:100-300 ELISA: 1/20000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from the C-terminal region of human SSX1/2/3/4/5/6/7/8/9. AA range:139-188
Subcellular Location
nucleus,
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Human Gen
6756
Observed Band
25kD
Other Name
CT5.1
CT5.2
CT5.3
CT5.4
Cancer/testis antigen 5.1
Cancer/testis antigen 5.2
Cancer/testis antigen 5.3
Cancer/testis antigen 5.4
Protein SSX1
Protein SSX2
Protein SSX3
Protein SSX4
Protein SSX5
Protein SSX7
Protein SSX8
Protein SSX9
Putative protein SSX6
SSX1
SSX2
SSX2A
SSX2B
SSX3
SSX4
SSX4A
SSX4B
SSX5
SSX6
SSX7
SSX8
SSX9
Synovial sarcoma, X breakpoint 1
Synovial sarcoma, X breakpoint 2
Tumor antigen HOM-MEL-40
Background
18)(p11.2
The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune respons
q11.2) translocations that are characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are